Get the Stockscreener App
151.33
3.53%
5.27
Natera Inc stock is traded at $151.33, with a volume of 1.08M.
It is up +3.53% in the last 24 hours and up +23.54% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$146.06
Open:
$150.6
24h Volume:
1.08M
Relative Volume:
0.93
Market Cap:
$18.88B
Revenue:
$1.36B
Net Income/Loss:
$-292.12M
P/E Ratio:
-31.40
EPS:
-4.82
Net Cash Flow:
$-107.32M
1W Performance:
+12.87%
1M Performance:
+23.54%
6M Performance:
+42.03%
1Y Performance:
+182.53%
1-Day Range:
$148.58
$155.23
1-Week Range:
$133.01
$167.79
52-Week Range:
$53.31
$167.79
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| NTRA | 151.25 | 18.88B | 1.36B | -292.12M | -107.32M | -4.82 |
| TMO | 499.96 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 229.46 | 165.90B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.17 | 36.48B | 6.50B | 1.41B | 1.42B | 3.82 |
| IDXX | 421.18 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
| IQV | 190.48 | 34.31B | 15.32B | 1.41B | 1.96B | 5.95 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Piper Sandler Issues Positive Forecast for Natera (NASDAQ:NTRA) Stock Price - MarketBeat
First Week of July 2025 Options Trading For Natera (NTRA) - Nasdaq
Sunday Insider Moves: Top Buys and Sells in US Stocks on November 17 - Investing.com
Empowered Funds LLC Invests $5.33 Million in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Steven Leonard Chapman Sells 4,728 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - MarketBeat
Insider Sale: CEO and President Steven Chapman Sells Shares of N - GuruFocus.com
Victory Capital Management Inc. Has $40.06 Million Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Oppenheimer Asset Management Inc. Acquires 4,267 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Director Gail Boxer Marcus Sells 2,212 Shares - MarketBeat
Natera Exec Calls Guardant's Cancer Test Claims 'Dangerous' - Law360
Natera director Roy Baynes sells stock worth $5.44 million - Investing.com
Natera CEO Steven Leonard Chapman sells shares worth $692,209 - Investing.com
Natera co-founder Sheena Jonathan sells $5.62 million in stock By Investing.com - Investing.com South Africa
Natera director Marcus Gail Boxer sells $350,671 in stock By Investing.com - Investing.com UK
Natera director Marcus Gail Boxer sells $350,671 in stock - Investing.com India
Natera's (NTRA) MRD Testing Fuels Investment Surge Amid Growing Demand - GuruFocus.com
Leerink Partnrs Issues Positive Estimate for Natera Earnings - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$158 - Simply Wall St
Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance
Natera, Inc. (NASDAQ:NTRA) Q3 2024 Earnings Call Transcript - MSN
Sumitomo Mitsui Trust Group Inc. Grows Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Stanley Druckenmiller's Strategic Emphasis on Natera Inc in Q3 2024 - GuruFocus.com
Natera Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
GSA Capital Partners LLP Sells 21,977 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera (NTRA) Stock Surges 20%: Q3 Revenue Up 64% as Test Volumes Hit Record Levels - MoneyCheck
Natera stock target boosted, retains buy rating on strong earnings By Investing.com - Investing.com Canada
Natera stock target boosted, retains buy rating on strong earnings - Investing.com India
Natera (NASDAQ:NTRA) Stock Rating Lowered by StockNews.com - MarketBeat
Natera’s Revenue Soars with Improved Margins and Cash Flow - Value the Markets
Guardant Atty Accuses Natera CEO Of Dishonesty At Trial - Law360
U.S. Indexes Ended Wednesday Mixed As Natera Led, Maplebear Lagged - Barron's
Natera Analysts Increase Their Forecasts Following Upbeat Results - Benzinga
U.S. STOCKS BankUnited, Natera, Adaptimmune - XM
Natera, Rivian lead Wednesday's market cap stock movers By Investing.com - Investing.com Nigeria
Natera Stock Explodes 20% After Record-Breaking Q3--Is This Biotech Giant Just Getting Started? - GuruFocus.com
Natera, Rivian lead Wednesday's market cap stock movers - Investing.com
Natera (NASDAQ:NTRA) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
Paymentus Posts Better-Than-Expected Earnings, Joins Dave, Honest Company, Natera, CAVA Group And Other Big Stocks Moving Higher On Wednesday - Benzinga
Robert W. Baird Forecasts Strong Price Appreciation for Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera (NASDAQ:NTRA) Issues Earnings Results - MarketBeat
Natera (NASDAQ:NTRA) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
Natera price target raised to $185 from $150 at BTIG - TipRanks
S&P 500 Futures Drop in Premarket Trading; Rocket Lab USA, CAVA Group Lead - Barron's
Natera price target raised to $160 from $135 at JPMorgan - TipRanks
WCM Investment Management LLC Sells 112,444 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera price target raised to $165 from $150 at Canaccord - TipRanks
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer - BioSpace
Natera: Q3 Earnings Snapshot - Houston Chronicle
Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ... - Yahoo Finance
Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ... By GuruFocus - Investing.com Canada
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Natera Inc Stock (NTRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Baynes Roy D. | Director |
Nov 15 '24 |
Sale |
146.11 |
37,230 |
5,439,565 |
15,807 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Nov 15 '24 |
Sale |
146.41 |
4,728 |
692,209 |
185,034 |
| Sheena Jonathan | CO-FOUNDER |
Nov 13 '24 |
Sale |
153.54 |
20,000 |
3,070,769 |
259,772 |
| Sheena Jonathan | CO-FOUNDER |
Nov 13 '24 |
Sale |
156.48 |
16,300 |
2,550,628 |
47,782 |
| Marcus Gail Boxer | Director |
Nov 14 '24 |
Sale |
158.53 |
2,212 |
350,672 |
19,386 |
1.53%
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):